Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-000020
Filing Date
2020-01-02
Accepted
2020-01-02 16:20:42
Documents
1
Period of Report
2019-12-27

Document Format Files

Seq Description Document Type Size
1 delmarph_fm4dec312019.html 4  
1 delmarph_fm4dec312019.xml 4 5752
  Complete submission text file 0000905718-20-000020.txt   7161
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 SAN MATEO DR MENLO PARK CA 94025
Business Address
Brown Dennis M (Reporting) CIK: 0001569520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 20501796